EichorEICHOR
Study identifier: NCT03859453 Synced from ClinicalTrials.gov · August 10, 2026
● Study status: Completed

Follow-up in Early and Locally Advanced Breast Cancer Patients

Condition: Breast Cancer  ·  Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

PhaseN/A
Planned participants830
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNoCheck eligibility criteria ↓
Where28 locations · 10 countries
For sponsors, CROs & site teams
Professional view of this study — listed sites, countries and recruiting context from the public registry. Everything below is written for patients and caregivers.See where this study is running →

About this study

A cross-sectional follow-up study of Early and Locally Advanced Breast Cancer patients after primary treatment.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: * Histologically proven Early Breast Cancer (EBC) and Locally Advanced Breast Cancer (LABC) patients who have completed their primary treatment (except endocrine therapy), between 12 months and 36 months after the diagnosis. * Disease-free without any evidence of relapse * Age ≥ 18 years. * Ability to understand and fill out questionnaires. * Written informed consent. Exclusion Criteria: * Metastatic breast cancer (defined as secondary spread to other organs, such as bones, lung, liver, mediastinal lymph nodes) or DCIS. * Other cancer diagnosis in the past 5 years except non-melanotic skin cancer or cervical intraepithelial neoplasia. * Male breast cancer. * Patients on maintenance therapy (other than endocrine therapy). * Patients participating in interventional clinical studies with Quality of Life as primary endpoint. * Any psychological (including preexisting psychiatric disorders), familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (28)

Onze Lieve Vrouw ZiekenhuisAalst, Belgium
CHU Saint Pierre - CHU Saint-Pierre-Site Porte de HalBrussels, Belgium
Cliniques Universitaires Saint-LucBrussels, Belgium
C.H.U. Sart-TilmanLiège, Belgium
CHU-UCL Namur - CHU Site Sainte-Elisabeth-UCL NamurNamur, Belgium
Assistance Publique Hopitaux Paris - Assistance Publique - Hopitaux de Paris - Hopital TenonParis, De, France
Groupe Radiopole Artois - Centre de radiotherapie Marie CurieArras, France
Universitaetsklinikum Leipzig-Klinik fuer Strahlentherapie und RadioonkologieLeipzig, Germany
HELIOS Kliniken - Helios Klinikum Wuppertal - Klin. Univ. Witten / HerdeckeWuppertal, Germany
Ospedale Generale RegionaleBolzano, Italy
Azienda Ospedaliero-Universitaria CareggiFlorence, Italy
Ospedale San GerardoMonza, Italy

+ 16 more locations — full list on the registry record.

More studies in these areas

This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.

AalstBrusselsLiègeNamur

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →